Description
Description
Varenzin -CA1 (molidustat oral suspension) is indicated for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. It works by stimulating a cat’s body to produce its own erythropoietin (EPO). The main cause of anemia in CKD patients is the lack of erythropoietin (EPO), a renal hormone that controls the bone marrow’s production of red blood cells.
Varenzin-CA1 is the FIRST and ONLY FDA conditionally approved option for the treatment of CKD-related anemia in cats. it is a liquid given orally to the cat once daily for up to 28 days; treatment may be repeated as needed after a minimum seven-day pause. Approved for at-home treatment, no in-clinic injections needed. For cats 3.4 lb and over. Shelf life of 2 years
Uses
- Varenzin-CA1 is the FIRST and ONLY FDA conditionally approved option for the treatment of CKD-related anemia in cats.
For more information please click here:
Reviews
There are no reviews yet